用于注射水凝的共性功能化素酸-酸纳米管:用于疏水性药物输送的多腔平台
Giuseppe Cinà1, Marina Massaro1, Andrea Pappalardo2,3
1Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e Farmaceutiche (STEBICEF), Università di Palermo, Viale delle Scienze, Parco d'Orleans II, Ed. 17, 90128 Palermo, Italy.
Pharmaceuticals (Basel, Switzerland)
|September 27, 2025
概括
研究人员开发了用于药物输送的化体纳米管 (HNT) 纳米材料. 功能化的HNT改善了抗癌药物的溶解性和释放性,显示了改善癌症治疗的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 较差的水溶性限制了许多抗癌药物的治疗应用.
- 由于其结构和生物相容性,Halloysite纳米管 (HNT) 具有作为药物载体的潜力.
- 疏水性和正电荷药物带来了重大交付挑战.
研究的目的:
- 设计和开发基于化的新型混合纳米材料,以提高药物输送.
- 创建可注射和生物相容的系统,用于疏水性抗癌药物.
- 调查卡利沙功能化对药物释放概况的影响.
主要方法:
- 在化纳米管 (HNTs) 上共振地移植体[5]arene宏循环,以创建一个多腔平台.
- 将一种模拟性疏水药物PB4封装成原始的HNTs (HNTs/PB4) 和素功能化的HNTs (HNTs-Calix/PB4).
- 将含有药物的HNT纳入以拉波尼特为基础的硫类水凝,用于注射.
主要成果:
- 混合纳米材料的成功表征,证明了良好的负载效率和水 dispersibility.
- 药物释放动态的评估,显示原始HNTs的释放速度更快,以及calixarene功能化的HNTs的持续释放.
- 药物加载的水凝对MCF-7细胞的抗增殖活性保持不变,证实了药物的疗效.
结论:
- 这项研究提供了第一个共价性卡力沙林功能化化体的例子.
- 开发的基于化的混合纳米材料为药物输送提供了一个多功能平台.
- 可调节的释放配置使这些系统适应各种治疗策略和组合疗法.
更多相关视频
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


